Incanthera

Liverpool, United Kingdom

Incanthera develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific

$3.3M raised

Jun 2024

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Incanthera raised?

Incanthera has raised $3.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2024.

Who are Incanthera's investors?

Incanthera's investors include The North West Fund.

Where is Incanthera headquartered?

Incanthera is headquartered in Liverpool, United Kingdom.

What does Incanthera do?

Incanthera develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific

What stage is Incanthera at?

Incanthera is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 3, 2024.

MLA

"Incanthera — Funding & Investors." VCBacked, June 3, 2024, https://www.vcbacked.co/company/incanthera. Accessed July 2, 2026.

APA

VCBacked. (2024). Incanthera — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/incanthera

Wikipedia (cite web)

{{cite web |title=Incanthera — Funding & Investors |url=https://www.vcbacked.co/company/incanthera |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 3, 2024.